NCT00003601View on ClinicalTrials.gov

Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 23, 1999

Primary Completion Date

March 31, 2000

Study Completion Date

March 2, 2004

Conditions
Melanoma (Skin)
Interventions
DRUG

fenretinide

DRUG

tretinoin

Trial Locations (1)

19104

University of Pennsylvania Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003601 - Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome | Biotech Hunter | Biotech Hunter